A Study of Safety and Efficacy of DPP-4 inhibitor in the Treatment of type 2 diabetes in Kanagawa
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000014382
- Lead Sponsor
- Diabetes Committee, Kanagawa Physicians Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 860
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with a history of hypersensitivity to Sitagliptin 2) Patients who have history of diabetic ketoacidosis, or diabetic coma in the past 6 months 3) Patients with serious infectious disease, before operation, serious trauma 4) Patients with severe renal failure
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method